360 High-Risk Vulnerability Immunization Tool V2.0 vs Asimily Vulnerability Prioritization: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

Asimily Vulnerability Prioritization: Vulnerability prioritization platform for IoT, OT, and IoMT devices. built by Asimily. Core capabilities include Vulnerability ranking based on likelihood and impact analysis, Risk scoring from 0-100 with industry benchmarking, Risk Simulator for modeling mitigation strategies..

Both serve the Vulnerability Assessment market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Asimily Vulnerability Prioritization differentiates with Vulnerability ranking based on likelihood and impact analysis, Risk scoring from 0-100 with industry benchmarking, Risk Simulator for modeling mitigation strategies.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Asimily Vulnerability Prioritization is developed by Asimily. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and Asimily Vulnerability Prioritization serve similar Vulnerability Assessment use cases: both are Vulnerability Assessment tools. Review the feature comparison above to determine which fits your requirements.